Viva Biotech Holdings Cash Flow Quality Index
Viva Biotech Holdings cash flow quality index. Viva Biotech Holdings (VB0) has a Cash Flow Quality Index of 313.38x as of June 2023. Operating cash flow of €158.72 Million exceeds net income of €506.50K, indicating high earnings quality where cash backs reported profits. See financial agility of Viva Biotech Holdings to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Viva Biotech Holdings (2016–2024)
Cash flow quality index of Viva Biotech Holdings from 2016 to 2024. Historical Cash Flow Quality Index for Viva Biotech Holdings across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Viva Biotech Holdings cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Viva Biotech Holdings Cash Flow Quality Index by Year (2016–2024)
Viva Biotech Holdings cash flow quality index by year from 2016 to 2024. Year-by-year earnings quality comparison for Viva Biotech Holdings. For the full cash flow conversion analysis, see Viva Biotech Holdings cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | €373.99 Million | €167.29 Million | ▲ +725.9% |
| 2021 | 0.27x | €77.83 Million | €287.55 Million | ▲ +56.4% |
| 2019 | 0.17x | €46.01 Million | €265.90 Million | ▲ +29.4% |
| 2018 | 0.13x | €12.11 Million | €90.55 Million | ▼ -63.4% |
| 2017 | 0.37x | €27.89 Million | €76.26 Million | ▼ -57.6% |
| 2016 | 0.86x | €21.12 Million | €24.47 Million | — |